Skip to content
Screener

Evolv Technologies Holdings, Inc. EVLV Business Segments — Stock-Based Comp

Similar metrics at other companies

Spyre Therapeutics, Inc. logo
SYREReportable Segment — Stock-Based Comp
$12.81M+44.6%
Pacira BioSciences, Inc. logo
PCRXReportable Segment — Stock-Based Comp
$13.54M-7.0%
Ouster logo
OUSTReportable Segment — Stock-Based Comp
$1.69M+6.0%
DraftKings Inc. logo
DKNGReportable Segment — Stock-Based Comp
$82.55M-2.5%
CareTrust logo
CTREReportable Segment — Stock-Based Comp
$3.02M-0.1%
Energy Vault Holdings logo
NRGVReportable Segment — Stock-Based Comp
$4.37M-51.4%

Other financials

Income statement

See full
Revenue$43.8M+34.4%
Gross profit$22.0M+35.4%
Operating income-$10.6M+39.7%
Net income-$9.3M+77.1%
EPS (diluted)-$0.05+80.0%

Balance sheet

See full
Cash & equivalents$53.4M+44.6%
Total debt$41.6M+191%
Total equity$118.9M+28.3%
Total assets$302.0M+7.7%

Cash flow

See full
Operating cash flow$11.9M+463%
CapEx$6.4M+107%
Free cash flow$12.6M+1,346%

Valuation

See full
Market cap$1.05B-11.8%
Enterprise value$1.04B-11.1%
P/S6.2×-3.7×

Profitability

See full
Gross margin49.9%-6.3pp
Operating margin-20.8%-8.1pp
Net margin-43.8%-8.7pp
FCF margin13.3%

Returns & leverage

See full
Return on equity-51.7%+24.4pp
Debt / equity0.3×+0.2×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by Evolv Technologies Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Evolv Technologies Holdings, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:57 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001805385-26-000049
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Segment revenue$43,753$32,544$90,081$64,551
Less:
Employee expense17,96915,73937,23932,108
Stock-based compensation expense16,8535,54712,4409,901
Other non-recurring expenses29036,81280410,373
Consulting and contract staffing2,6643,0465,7586,323
Depreciation and amortization7,1375,79013,93811,319
Restructuring costs2,662

Item 1. Financial Statements

FAQ

What is Evolv Technologies Holdings, Inc.'s business segments — stock-based comp?
Evolv Technologies Holdings, Inc. (EVLV) reported business segments — stock-based comp of $6.85M in Q2 2026.
How has Evolv Technologies Holdings, Inc.'s business segments — stock-based comp changed year-over-year?
Evolv Technologies Holdings, Inc.'s business segments — stock-based comp increased by 23.5% year-over-year, from $5.55M to $6.85M.
What is the long-term trend for Evolv Technologies Holdings, Inc.'s business segments — stock-based comp?
Over 3 years (2022 to 2025), Evolv Technologies Holdings, Inc.'s business segments — stock-based comp has grown at a -3.0% compound annual growth rate (CAGR), from $22.52M to $20.57M.
What does business segments — stock-based comp mean?
Reflects the non-cash expense recognized for equity-based awards granted to employees and contractors within the segment. This metric is critical for understanding the true cost of talent acquisition and retention beyond cash-based payroll.

Ask your AI about Evolv Technologies Holdings, Inc.'s business segments — stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude